Navigation Links
Experiments on Mount Everest to Study Oxygen Deprivation Effect

To study the effects of oxygen deprivation on the human body, a group of doctors from the University College, London would be trekking// all the way to Mount Everest, the highest point on earth, it has been announced.

Oxygen deprivation is a critical problem for patients in intensive care units, it must be remembered. On Mount Everest, the highest point on earth, the amount of oxygen available is only one-third of what exists at sea-level. Hence the peak is considered ideal for the study.

The team will set off on its path-breaking expedition on March 17 and right through April they would be performing a variety of experiments on themselves and on over 200 volunteers at base camp (5,300 metres) at Kathmandu.

The tests range from measuring subjects' blood flow speed and monitoring the impact of altitude on their mental functions. They would also be working on an exercise bike during the experiments.

Comparing the sea and altitude level reactions will help the team find out what physiological changes occur in such conditions. It could also help scientists find out why some people cope better with low oxygen levels.

Expedition leader Dr Mike says the Mount Everest tests would enable doctors to cope better with patients rushed to the ICU.
'"/>




Page: 1

Related medicine news :

1. New Technique For Science Experiments
2. Experiments In Outer Space To Determine single Cell Survival
3. Mountain biking connected to infertility
4. Spread Of Rocky Mountain Spotted Fever Is A Probability, Say Experts
5. Epidemic Fear In Mumbai Mounting Post-Floods
6. Non-Communicable Diseases Mounting Up At An Alarming Rate in India
7. Illegal Drug Use In England Mounting Up At An Alarming Rate
8. Indonesia Has Ninth Bird-Flu Death as Risk Mounts
9. Mountain Biking Results In Serious Injuries
10. CNIC To Provide Funds To Mount Sinai School
11. Mount Everest to be Site of Research into Hypoxia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... VA (PRWEB) , ... March 27, 2017 , ... ... application containerization, today announced it will co-exhibit with technology partners LG Business Solutions ... at the Marriott Metro Center in Washington D.C., will provide education and examination ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... the CE Certificate of Conformity for the Smart System® 20/20. CE Certification builds ... highest industry standards and specifications such as ANSI, ISO and proven test methods ...
(Date:3/27/2017)... ... 2017 , ... Osteitis pubis may be commonplace and seemingly ... occurs when the muscles around the pelvis become inflamed. Over time, untreated osteitis ... as well as accompanying tenderness and weakness. Without proper intervention, it can hinder ...
(Date:3/27/2017)... ... March 27, 2017 , ... EpiGentek , a Farmingdale, ... recent RNA methylation “gold rush” with their established portfolio of optimized assay kits ... N6-methyladenosine, or m6A , RNA methylation has received a new burst in ...
(Date:3/27/2017)... San Mateo, CA (PRWEB) , ... March 27, 2017 , ... Janet Schloz is still ... one of the best days I’ve had in a long time,” she said. , She ... a lot of money that I never thought I would have to help my students.” ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Pulmatrix, Inc . (NASDAQ: PULM), a clinical stage biopharmaceutical company ... announced that it has added two experts in the fields ... Scientific Advisory Board . The two experts ... MD, former chief of the Pediatric Pulmonary and Allergy Divisions ... University, and David Denning , MD, ...
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017 ...  is expected to reach USD 16.0 billion by 2025, ... Inc. The growing prevalence of chronic diseases is anticipated ... clinical chemistry analyzers, which thereby widens the scope for ... of geriatric and bariatric population, which is highly susceptible ...
(Date:3/27/2017)... DUBLIN and BOSTON ... AGN), a leading global pharmaceutical company and Paratek ... on the development and commercialization of innovative therapies ... Phase 3 trials of sarecycline for the treatment ... week primary efficacy endpoints. Sarecycline is a once-daily, ...
Breaking Medicine Technology: